Sintx Technologies (SINT) Preferred Stock Liabilities (2013)
Sintx Technologies (SINT) posted Preferred Stock Liabilities of $161.5 million for Q4 2013.
Powered by 
Analysis
Sintx Technologies (SINT) Preferred Stock Liabilities (2013) Analysis & Trends
Sintx Technologies has reported Preferred Stock Liabilities for 1 years, with the latest figure at $161.5 million in Q4 2013.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $161.5 million in Q4 2013; TTM through Dec 2013 was $161.5 million, a N/A change from a year earlier, with the FY2013 full-year figure at $161.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities was $161.5 million for Q4 2013 at Sintx Technologies.
- The five-year high for Preferred Stock Liabilities was $161.5 million in Q4 2013, with the low at $161.5 million in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | - |